advanced non-small cell lung cancerpembrolizumab
… occurrence.Methods We retrospectively identified patients with advanced non-small cell lung cancer who switched pembrolizumab from Q3W to Q6W between March 2017 a…
15articles mentioning diseases
15disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: advanced non-small cell lung cancer ×
advanced non-small cell lung cancer
This disease is selected. Its supporting articles are shown below.
Articles mentioning advanced non-small cell lung cancer
15 articles · page 1 of 2advanced non-small cell lung cancerimmunotherapyICIsimmune checkpoint inhibitors
… checkpoint inhibitors (ICIs) has transformed the management of advanced non-small cell lung cancer, establishing immunotherapy as a cornerstone of treatment. Howe…
76.1%
NSCLCadvanced non-small cell lung cancerNCCNimmunotherapiesASCOtargeted therapies
…advances in treatments for advanced non-small cell lung cancer (NSCLC), it remains the leading cause of cancer death globally. Dozens…
NSCLCadvanced non-small cell lung cancerchemotherapyICIs
…nd women treated with ICIs versus chemotherapy for stage III–IV NSCLC. Eligible studies compared programmed cell death protein 1/prog…
NSCLCadvanced non-small cell lung cancerICI
…expression <50%. TMB should be considered in future early-stage NSCLC ICI clinical trials to further validate these results.…
NSCLCadvanced non-small cell lung cancerimmunotherapyPRELUCAThe Committee on Health Research Ethics of Region Zealand
…cal Oncology treatment guidelines and permit broad inclusion of NSCLC patients, ensuring ‘real-world’ representativeness. The study u…
NSCLCadvanced non-small cell lung cancernivolumabipilimumabPembropembrolizumab-basedNivoNivo+Ipi
…ter, observational study retrospectively reviewed patients with NSCLC treated with first-line Pembro or Nivo+Ipi who had evaluable PD…
NSCLCadvanced non-small cell lung cancersolid tumorsICIimmune checkpoint inhibitors
…river alterations. Unfortunately, the majority of patients with NSCLC do not respond to ICI treatment or will eventually experience d…
PD-L1-negative NSCLCPD-L1-positive non-small-cell lung cancerNSCLCLung cancernon-small-cell lung cancerPD-L1-positive advanced non-small-cell lung canceradvanced non-small cell lung canceradvanced nonsquamous non-small-cell lung cancerstage IV or recurrent non-small-cell lung cancernivolumab
…bjective response rate (ORR).Results Twenty-seven patients with PD-L1-negative NSCLC treated with chemoimmunotherapy were included. At a median foll…
metastatic melanomaaNSCLCES-SCLCadvanced non-small cell lung cancerkidney cancerextensive-stage small cell lung cancermelanomaRCCskin cancersmetastatic renal cell carcinoma+1 more
…for all indications (A), metastatic RCC and kidney cancers (B), metastatic melanoma and skin cancers (C), and extensive-stage SCLC (D). Predetermin…
bilateral non-small cell lung cancerCOPDcolorectal cancerpulmonary metastasis only diseaseILDadvanced non-small cell lung cancerNorthwestern Memorial Hospitaldurvalumabatezolizumabtoripalimab+4 more
…Malignancies (DREAM) study ( NCT05671887) across three cohorts: bilateral non-small cell lung cancer, pulmonary metastasis only disease, and history of malignancy w…
NSCLCLewis lung carcinomaadvanced non-small cell lung cancer
…T cells (Tregs; 8.09% vs. 4.18%, P < 0.05) in anti-PD-1-treated NSCLC patients compared to untreated controls. These findings implica…